Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Kura Oncology

The promise of precision oncology brought to life for patients

## Sitemaps

- [XML Sitemap](https://kuraoncology.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [San Diego Business Journal CEO of the Year Awards 2023 Finalists](https://kuraoncology.com/leadership-in-the-news/san-diego-business-journal-ceo-of-the-year-awards-2023-finalists/)
- [Fostering a Workplace Place for Innovators to Thrive](https://www.linkedin.com/pulse/fostering-workplace-place-innovators-thrive-kathy-ford-9xhoe/?trackingId=APOTPJFkTXKDllKoBr0mug==#new_tab)
- [Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends](https://scrip.citeline.com/SC149726/Scrip-AsksWhat-Does-2024-Hold-For-Biopharma-Part-5-Clinical-Trial-Trends#new_tab)
- [PharmaVoice’s Crystal Ball: Perspectives on the financial future](https://www.pharmavoice.com/news/pharma-preview-biotech-financial-outlook/703706/#new_tab)
- [Kathy Ford, R.N., B.S.N., Kura COO, on Ordinarily Extraordinary - Conversations with Women in STEM podcast](https://ordinarily-extraordinary.com/episode-121-kathy-ford/#new_tab)
- [Dr. Erba provides an overview of the KOMET clinical trial program](https://vimeo.com/896728209)
- ["Project Optimus encourages optimal biological dosing rather than maximally tolerated dosing." — Harry Erba, MD, PhD](https://vimeo.com/896728112)
- [Dr. Erba explains the different combinations KOMET-008 will evaluate and how it differs from KOMET-007](https://vimeo.com/896727997)
- [Dr. Erba offers insight into the KOMET-007 Phase 1 trial and rationale for investigating ziftomenib in combination with standards of care for the treatment of patients with newly diagnosed or R/R NPM1-m or KMT2A-r AML](https://vimeo.com/896727759)
- [Dr. Erba discusses the KOMET-001 Phase 1b safety and tolerability data of ziftomenib, a menin inhibitor, for patients with R/R NPM1-m AML](https://vimeo.com/896727644)
- [Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place](https://www.lifescienceleader.com/doc/manufacturing-and-supply-chain-making-space-between-a-rock-and-a-hard-place-0001#new_tab)
- [The Promise of Precision Oncology, Troy Wilson, President & CEO, Kura Oncology](https://www.biotech2050.com/episodes/the-promise-of-precision-oncology-troy-wilson-president-amp-ceo-kura-oncology#new_tab)
- [Kura Oncology's CEO gives an update on Q3 earnings](https://vimeo.com/880632171/2139d50980?share=copy)
- [PharmaVoice 100 Top Industry Leaders: Teresa Bair, J.D.](https://kuraoncology.com/leadership-in-the-news/pharmavoice-100-top-industry-leaders-teresa-bair-j-d/)
- [Dr. Fathi presents the latest KOMET-001 data](https://vimeo.com/866056289)
- [Evaluating ziftomenib in combinations for patients who are newly diagnosed or relapsed/refractory NPM1m or KMT2Ar AML](https://vimeo.com/857340736)
- [Emerging advancements in acute myeloid leukemia](https://vimeo.com/837043997)
- [Mechanism of action for investigational menin inhibitors, including ziftomenib](https://vimeo.com/852839496)
- [NPM1 mutations in acute myeloid leukemia: actionable mutations to inform treatment decisions with clinical trials](https://vimeo.com/852839881)
- [Can you give a brief overview of unmet medical needs within NPM1-mutated acute myeloid leukemia?](https://vimeo.com/837043843)
- [The Medicine Maker Power List 2023: Francis Burrows](https://kuraoncology.com/leadership-in-the-news/the-medicine-maker-power-list-2023-francis-burrows/)
- [San Diego Business Journal Leaders of Influence in Life Sciences 2023 Honorees](https://kuraoncology.com/leadership-in-the-news/san-diego-business-journal-leaders-of-influence-in-life-sciences-2023-honorees/)
- [What pharma can teach biotech about the life cycle management of a drug](https://kuraoncology.com/leadership-in-the-news/what-pharma-can-teach-biotech-about-the-life-cycle-management-of-a-drug-2/)
- [What pharma can teach biotech about the life cycle management of a drug](https://kuraoncology.com/currents/what-pharma-can-teach-biotech-about-the-life-cycle-management-of-a-drug/)
- [Navigating dose optimization requirements as a small biotech](https://kuraoncology.com/currents/february-1-2023-navigating-dose-optimization-requirements-as-a-small-biotech/)
- [Liquid Biopsies Guide the Development of Cancer Drugs](https://www.genengnews.com/topics/cancer/liquid-biopsies-guide-the-development-of-cancer-drugs/)
- [Fierce Biotech: FDA’s renewed focus on oncology dosing spooks investors, but companies say they’re ready](https://kuraoncology.com/currents/fierce-biotech-fdas-renewed-focus-on-oncology-dosing-spooks-investors-but-companies-say-theyre-ready/)
- [BIO: Kura Oncology CEO Wilson on the power of biotech in the quest beyond KRAS](https://kuraoncology.com/leadership-in-the-news/bio-kura-oncology-ceo-wilson-on-the-power-of-biotech-in-the-quest-beyond-kras/)
- [ESMO: Tipifarnib demonstrates encouraging efficacy in patients with recurrent and/or metastatic hnscc with hras mutations](https://kuraoncology.com/currents/esmo-tipifarnib-demonstrates-encouraging-efficacy-in-patients-with-recurrent-and-or-metastatic-hnscc-with-hras-mutations/)
- [Journal of Clinical Oncology: Is This the Dawn of Precision Oncology in Head and Neck Cancer?](https://kuraoncology.com/currents/journal-of-clinical-oncology-is-this-the-dawn-of-precision-oncology-in-head-and-neck-cancer/)

## Pages

- [Home](https://kuraoncology.com/) - Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
- [About Us](https://kuraoncology.com/about-us/) - We aim to help patients with cancer achieve long-lasting remission through targeted, well-tolerated treatments.
- [Posters and Presentations](https://kuraoncology.com/pipeline/posters-and-presentations/)
- [Cookie Policy](https://kuraoncology.com/cookie-policy/)
- [Komzifti](https://kuraoncology.com/komzifti/)
- [Media Resources](https://kuraoncology.com/newsroom/media-resources/) - Essential assets such as logos and images related to Kura Oncology.
- [Careers](https://kuraoncology.com/careers/) - We’re here to change the currents of disease. Our goal is to help patients with cancer lead better, longer lives. Our team is made up of the experts to help realize it.
- [Pipeline v3](https://kuraoncology.com/pipeline/pipeline-v3/) - Our programs consist of small molecule drug candidates that target cancer signaling pathways, where each program builds on our expertise in precision medicines
- [Newsroom](https://kuraoncology.com/newsroom/) - News & Media, Press Releases, News & Perspectives, Expert Perspectives, Media Resources
- [Pipeline](https://kuraoncology.com/pipeline/) - We are advancing a diverse pipeline of precision medicines for the treatment of blood cancers and solid tumors.
- [Access To Investigational Drugs Outside a Clinical Study](https://kuraoncology.com/pipeline/access-to-investigational-drugs-outside-a-clinical-study/) - Kura Oncology is committed to realizing the promise of precision medicines for the treatment of cancer. To do this, we conduct clinical studies
- [Compliance Declaration](https://kuraoncology.com/about-us/compliance-declaration/)
- [Terms of Use](https://kuraoncology.com/terms-of-use/) - The following Terms of Use govern and apply to your use and/or reliance upon this and any website maintained Kura Oncology, Inc.
- [Contact](https://kuraoncology.com/contact/) - SAN DIEGO 12730 High Bluff Drive, Suite 400 San Diego, CA 92130 (858) 500-8800 5510 Morehouse Drive, Suite 110 San Diego, California 92121
- [Footer](https://kuraoncology.com/footer/) - About Us Our Approach Pipeline Clinical Trials Patients & Caregivers Investors Contact News & Media Careers
- [Patients and Caregivers](https://kuraoncology.com/patients-and-caregivers/) - Kura Oncology is a clinical stage pharmaceutical company whose goal is to help people with cancer to lead better, longer lives.
- [Privacy Policy](https://kuraoncology.com/privacy-policy/) - Kura Oncology, Inc. values and respects your privacy. This Privacy Policy is designed to assist you in understanding how we collect, use, and protect personal
- [Consumer Health Data](https://kuraoncology.com/consumer-health-data/)
- [Head & Neck](https://kuraoncology.com/patients-and-caregivers/head-neck/) - Though any cancer diagnosis can be hard to contend with, you are not alone. Head and neck cancer may be more common than you think.
- [Acute Leukemias](https://kuraoncology.com/patients-and-caregivers/acute-leukemias/) - Acute myeloid leukemia is a type of blood cancer that starts in bone marrow, and affects the development of red blood cells, white blood cells, and platelets.
- [Investigator Sponsored Studies](https://kuraoncology.com/grants-funding/investigator-sponsored-studies/) - Applicants to help address legitimate medical or scientific questions affecting the use of Kura Oncology’s investigational compounds.
- [Grants & Funding](https://kuraoncology.com/grants-funding/) - Independent Medical Education Grants Program provides support funding to organizations that provide healthcare provider education and advance patient care
- [Our Approach](https://kuraoncology.com/our-approach/) - With the advent of precision medicines that can target unique molecular or genetic features of a patient’s tumor, the field of oncology has a host of alternatives to one-size-fits-all treatments.
- [The Story Behind Our Name](https://kuraoncology.com/about-us/the-story-behind-our-name/) - The origins of Kura Oncology began to emerge years before the company launched in 2014.
- [Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia](https://kuraoncology.com/clinical-trials/update-on-a-phase-1-2-first-in-human-study-of-the-menin-kmt2a-mll-inhibitor-ziftomenib-ko-539-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia/)
- [Komet Preliminary Data](https://kuraoncology.com/clinical-trials/komet-preliminary-data/)

## Leadership

- [Troy Wilson, Ph.D., J.D.](https://kuraoncology.com/leadership/troy-wilson-ph-d-j-d-2/)
- [Troy Wilson, Ph.D., J.D.](https://kuraoncology.com/leadership/troy-wilson/)
- [Francis Burrows, Ph.D.](https://kuraoncology.com/leadership/francis-burrows/)
- [Michael Vasconcelles, M.D.](https://kuraoncology.com/leadership/michael-vasconcelles-m-d/)
- [Mary Szela](https://kuraoncology.com/leadership/mary-szela/)
- [Carol Schafer](https://kuraoncology.com/leadership/carol-schafer/)
- [Diane Parks](https://kuraoncology.com/leadership/diane-parks/)
- [Thomas Malley](https://kuraoncology.com/leadership/thomas-malley/)
- [Helen Collins, M.D.](https://kuraoncology.com/leadership/helen-collins-m-d/)
- [Faheem Hasnain](https://kuraoncology.com/leadership/faheem-hasnain/)
- [Samir Vattompadam](https://kuraoncology.com/leadership/samir-vattompadam/)
- [Roger Bakale, Ph.D.](https://kuraoncology.com/leadership/roger-bakale-ph-d/)
- [Brian Powl](https://kuraoncology.com/leadership/brian-powl/)
- [Tom Doyle](https://kuraoncology.com/leadership/tom-doyle/)
- [Mollie Leoni, M.D.](https://kuraoncology.com/leadership/mollie-leoni/)
- [Kathleen Ford](https://kuraoncology.com/leadership/kathleen-ford/)
- [Teresa Bair, J.D.](https://kuraoncology.com/leadership/teresa-bair/)

## CT Locations

- [Northwestern University](https://kuraoncology.com/ct-locations/northwestern-university/)
- [Massachusetts General Hospital](https://kuraoncology.com/ct-locations/massachusetts-general-hospital/)
- [University of Michigan Hospitals](https://kuraoncology.com/ct-locations/university-of-michigan-hospitals/)
- [Roswell Park Comprehensive Cancer Center](https://kuraoncology.com/ct-locations/roswell-park-comprehensive-cancer-center/)
- [MD Anderson Cancer Center](https://kuraoncology.com/ct-locations/md-anderson-cancer-center-2/)
- [UCLA Bowyer Oncology Center](https://kuraoncology.com/ct-locations/ucla-bowyer-oncology-center/)
- [University of Maryland Greenebaum Comprehensive Cancer Center](https://kuraoncology.com/ct-locations/university-of-maryland-greenebaum-comprehensive-cancer-center/)
- [Mayo Clinic](https://kuraoncology.com/ct-locations/mayo-clinic-2/)
- [Vanderbilt-Ingram Cancer Center](https://kuraoncology.com/ct-locations/vanderbilt-ingram-cancer-center/)
- [Mayo Clinic](https://kuraoncology.com/ct-locations/mayo-clinic-3/)
- [Harold C. Simmons Comprehensive Cancer Center - UT Southwestern Medical Center](https://kuraoncology.com/ct-locations/harold-c-simmons-comprehensive-cancer-center-ut-southwestern-medical-center/)
- [UPMC Hillman Cancer Center](https://kuraoncology.com/ct-locations/upmc-hillman-cancer-center/)
- [Banner MD Anderson Cancer Center](https://kuraoncology.com/ct-locations/banner-md-anderson-cancer-center/)
- [Mayo Clinic](https://kuraoncology.com/ct-locations/mayo-clinic-4/)
- [Karmanos Cancer Institute](https://kuraoncology.com/ct-locations/karmanos-cancer-institute/)
- [The Mount Sinai Hospital](https://kuraoncology.com/ct-locations/the-mount-sinai-hospital/)
- [Weill Cornell Medical College - NY Presbyterian Hospital](https://kuraoncology.com/ct-locations/weill-cornell/)
- [Hackensack University Medical Center](https://kuraoncology.com/ct-locations/hackensack-university-medical-center/)
- [University of Southern California](https://kuraoncology.com/ct-locations/university-of-southern-california/)
- [Medizinische Hochsschule Hannover](https://kuraoncology.com/ct-locations/medizinische-hochsschule-hannover/)
- [University Medicine Greifswald](https://kuraoncology.com/ct-locations/university-medicine-greifswald/)
- [Magendie Hopital Haut-Leveque](https://kuraoncology.com/ct-locations/magendie-hopital-haut-leveque/)
- [Hospital Universitario HM Sanchinarro](https://kuraoncology.com/ct-locations/hospital-universitario-sanchinarro/)
- [Indiana University Melvin and Bren Simon Comprehensive Cancer Center](https://kuraoncology.com/ct-locations/indiana-university-melvin-and-bren-simon-comprehensive-cancer-center/)
- [AOU di Bologna - Policlinico di Saint'Orsola-Malpighi](https://kuraoncology.com/ct-locations/aou-di-bologna-policlinico-di-saintorsola-malpighi/)
- [Oklahoma University Health - Stephenson Cancer Center](https://kuraoncology.com/ct-locations/oklahoma-university-health-stephenson-cancer-center/)
- [Duke Cancer Institute](https://kuraoncology.com/ct-locations/duke-cancer-institute/)
- [University of Wisconsin Carbone Cancer Center](https://kuraoncology.com/ct-locations/university-of-wisconsin-carbone-cancer-center/)
- [University of Texas MD Anderson Cancer Center](https://kuraoncology.com/ct-locations/university-of-texas-md-anderson-cancer-center/)
- [UT Southwestern Medical Center (Harold C. Simmons Comprehensive Cancer Center)](https://kuraoncology.com/ct-locations/ut-southwestern-medical-center-harold-c-simmons-comprehensive-cancer-center/)
- [Johns Hopkins University School of Medicine (Sidney Kimmel Comprehensive Cancer Center)](https://kuraoncology.com/ct-locations/johns-hopkins-university-school-of-medicine-sidney-kimmel-comprehensive-cancer-center/)
- [University of Maryland School of Medicine (Marlene and Stewart Greenebaum Comprehensive Cancer Center)](https://kuraoncology.com/ct-locations/university-of-maryland-school-of-medicine-marlene-and-stewart-greenebaum-comprehensive-cancer-center/)
- [Hospital Universitari Vall d'Hebron](https://kuraoncology.com/ct-locations/hospital-universitari-vall-dhebron-2/)
- [Lake Nona DDU (Florida Cancer Specialists)](https://kuraoncology.com/ct-locations/lake-nona-ddu-florida-cancer-specialists/)
- [City of Hope Comprehensive Cancer Center](https://kuraoncology.com/ct-locations/city-of-hope-comprehensive-cancer-center/)
- [Dana-Farber Cancer Institute (Head and Neck Cancer Treatment Center)](https://kuraoncology.com/ct-locations/dana-farber-cancer-institute-head-and-neck-cancer-treatment-center/)
- [Washington University, School of Medicine](https://kuraoncology.com/ct-locations/washington-university-school-of-medicine/)
- [UPMC Hillman Cancer Center](https://kuraoncology.com/ct-locations/upmc-hillman-cancer-center-2/)
- [Memorial Sloan Kettering Cancer Center](https://kuraoncology.com/ct-locations/memorial-sloan-kettering-cancer-center-2/)
- [Fred Hutchinson Cancer Research Center](https://kuraoncology.com/ct-locations/fred-hutchinson-cancer-research-center/)
- [Hospital Universitario Virgen del Rocio](https://kuraoncology.com/ct-locations/hospital-universitario-virgen-del-rocio-2/)
- [CHU de Nantes](https://kuraoncology.com/ct-locations/chu-de-nantes/)
- [CHU de Lille](https://kuraoncology.com/ct-locations/chu-de-lille/)
- [Centre Hospitalier Lyon Sud](https://kuraoncology.com/ct-locations/centre-hospitalier-lyon-sud/)
- [Hospital Universitario Central de Asturias](https://kuraoncology.com/ct-locations/hospital-universitario-central-de-asturias/)
- [Universitat de Barcelona](https://kuraoncology.com/ct-locations/universitat-de-barcelona/)
- [Hospital Universitari i Politecnic La Fe](https://kuraoncology.com/ct-locations/hospital-universitari-i-politecnic-la-fe/)
- [MD Anderson Cancer Center](https://kuraoncology.com/ct-locations/md-anderson-cancer-center/)
- [Hopital Saint Louis](https://kuraoncology.com/ct-locations/hopital-saint-louis/)
- [Institut Gustave Roussy](https://kuraoncology.com/ct-locations/institut-gustave-roussy/)
- [University of Wisconsin](https://kuraoncology.com/ct-locations/university-of-wisconsin/)
- [Seattle Cancer Care Alliance](https://kuraoncology.com/ct-locations/seattle-cancer-care-alliance/)
- [Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center](https://kuraoncology.com/ct-locations/vanderbilt-university-medical-center-vanderbilt-ingram-cancer-center/)
- [Fox Chase Cancer Center](https://kuraoncology.com/ct-locations/fox-chase-cancer-center/)
- [University of Oklahoma Health Sciences Center](https://kuraoncology.com/ct-locations/university-of-oklahoma-health-sciences-center/)
- [Levine Cancer Institute](https://kuraoncology.com/ct-locations/levine-cancer-institute/)
- [Memorial Sloan Kettering Cancer Center](https://kuraoncology.com/ct-locations/memorial-sloan-kettering-cancer-center/)
- [New York University Langone Medical Center](https://kuraoncology.com/ct-locations/new-york-university-langone-medical-center/)
- [Siteman Cancer Center - Washington University Medical Campus](https://kuraoncology.com/ct-locations/siteman-cancer-center-washington-university-medical-campus/)
- [Mayo Clinic](https://kuraoncology.com/ct-locations/mayo-clinic/)
- [Barbara Ann Karmanos Cancer Institute](https://kuraoncology.com/ct-locations/barbara-ann-karmanos-cancer-institute/)
- [Dana Farber Cancer Institute](https://kuraoncology.com/ct-locations/dana-farber-cancer-institute/)
- [Marlene and Stewart Greenebaum Cancer Center](https://kuraoncology.com/ct-locations/marlene-and-stewart-greenebaum-cancer-center/)
- [Greater Baltimore Medical Center](https://kuraoncology.com/ct-locations/greater-baltimore-medical-center/)
- [Norton Cancer Institute](https://kuraoncology.com/ct-locations/norton-cancer-institute/)
- [University of Kentucky Markey Cancer Center](https://kuraoncology.com/ct-locations/university-of-kentucky-markey-cancer-center/)
- [University Of Kansas Medical Center](https://kuraoncology.com/ct-locations/university-of-kansas-medical-center/)
- [Winship Cancer Institute](https://kuraoncology.com/ct-locations/winship-cancer-institute/)
- [University of South Florida H. Lee Moffitt Cancer Center and Research Institute](https://kuraoncology.com/ct-locations/university-of-south-florida-h-lee-moffitt-cancer-center-and-research-institute/)
- [Miami Cancer Institute](https://kuraoncology.com/ct-locations/miami-cancer-institute/)
- [The Oncology Institute of Hope and Innovation - Anaheim](https://kuraoncology.com/ct-locations/the-oncology-institute-of-hope-and-innovation-anaheim/)
- [UCSF - Helen Diller Family Comprehensive Cancer Center](https://kuraoncology.com/ct-locations/ucsf-helen-diller-family-comprehensive-cancer-center/)
- [UCLA - Jonsson Comprehensive Cancer Center](https://kuraoncology.com/ct-locations/ucla-jonsson-comprehensive-cancer-center/)
- [NHS Greater Glasgow and Clyde](https://kuraoncology.com/ct-locations/nhs-greater-glasgow-and-clyde/)
- [University College London Hospitals NHS Foundation Trust](https://kuraoncology.com/ct-locations/university-college-london-hospitals-nhs-foundation-trust/)
- [The Royal Marsden NHS Foundation Trust](https://kuraoncology.com/ct-locations/the-royal-marsden-nhs-foundation-trust-2/)
- [The Christie NHS Foundation Trust](https://kuraoncology.com/ct-locations/the-christie-nhs-foundation-trust/)
- [The Royal Marsden NHS Foundation Trust](https://kuraoncology.com/ct-locations/the-royal-marsden-nhs-foundation-trust/)
- [King Chulalongkorn Memorial Hospital](https://kuraoncology.com/ct-locations/king-chulalongkorn-memorial-hospital/)
- [Maharaj Nakorn Chiang Mai Hospital](https://kuraoncology.com/ct-locations/maharaj-nakorn-chiang-mai-hospital/)
- [Songklanagarind Hospital](https://kuraoncology.com/ct-locations/songklanagarind-hospital/)
- [Changhua Christian Hospital](https://kuraoncology.com/ct-locations/changhua-christian-hospital/)
- [China Medical University Hospital](https://kuraoncology.com/ct-locations/china-medical-university-hospital/)
- [National Cheng Kung University Hospital](https://kuraoncology.com/ct-locations/national-cheng-kung-university-hospital/)
- [Mackay Memorial Hospital](https://kuraoncology.com/ct-locations/mackay-memorial-hospital/)
- [National Taiwan University Hospital](https://kuraoncology.com/ct-locations/national-taiwan-university-hospital/)
- [Chang Gung Memorial Hospital](https://kuraoncology.com/ct-locations/chang-gung-memorial-hospital/)
- [Chang Gung Medical Foundation Keelung Chang Gung Memorial Hospital](https://kuraoncology.com/ct-locations/chang-gung-medical-foundation-keelung-chang-gung-memorial-hospital/)
- [Hospital del Mar - Parc de Salut Mar](https://kuraoncology.com/ct-locations/hospital-del-mar-parc-de-salut-mar/)
- [Hospital de la Santa Creu i de Sant Pau](https://kuraoncology.com/ct-locations/hospital-de-la-santa-creu-i-de-sant-pau/)
- [Hospital Universitari Vall d'Hebrón](https://kuraoncology.com/ct-locations/hospital-universitari-vall-dhebron/)
- [Hospital Clinic i Provincial de Barcelona](https://kuraoncology.com/ct-locations/hospital-clinic-i-provincial-de-barcelona/)
- [Hospital Duran i Reynals](https://kuraoncology.com/ct-locations/hospital-duran-i-reynals/)
- [Hospital Universitario 12 de Octubre](https://kuraoncology.com/ct-locations/hospital-universitario-12-de-octubre/)
- [Hospital Universitario La Paz](https://kuraoncology.com/ct-locations/hospital-universitario-la-paz/)
- [HM Centro Integral Oncológico Clara Campal](https://kuraoncology.com/ct-locations/hm-centro-integral-oncologico-clara-campal/)
- [Hospital Costa Del Sol](https://kuraoncology.com/ct-locations/hospital-costa-del-sol/)
- [Hospital Universitario Virgen de la Victoria](https://kuraoncology.com/ct-locations/hospital-universitario-virgen-de-la-victoria/)
- [Complejo Hospitalario de Navarra](https://kuraoncology.com/ct-locations/complejo-hospitalario-de-navarra/)
- [Hospital Clínico Universitario de Santiago de Compostela](https://kuraoncology.com/ct-locations/hospital-clinico-universitario-de-santiago-de-compostela/)
- [Hospital Universitario Virgen del Rocio](https://kuraoncology.com/ct-locations/hospital-universitario-virgen-del-rocio/)
- [Hospital Universitari i Politecnic La Fe de Valencia](https://kuraoncology.com/ct-locations/hospital-universitari-i-politecnic-la-fe-de-valencia/)
- [Hospital Universitario Miguel Servet](https://kuraoncology.com/ct-locations/hospital-universitario-miguel-servet/)
- [National Cancer Center](https://kuraoncology.com/ct-locations/national-cancer-center/)
- [Chonbuk National University Hospital](https://kuraoncology.com/ct-locations/chonbuk-national-university-hospital/)
- [Korea University Anam Hospital](https://kuraoncology.com/ct-locations/korea-university-anam-hospital/)
- [Yonsei University Health System Severance Hospital](https://kuraoncology.com/ct-locations/yonsei-university-health-system-severance-hospital/)
- [Asan Medical Center](https://kuraoncology.com/ct-locations/asan-medical-center/)
- [Samsung Medical Center](https://kuraoncology.com/ct-locations/samsung-medical-center/)
- [The Catholic University of Korea - Seoul St. Mary's Hospital](https://kuraoncology.com/ct-locations/the-catholic-university-of-korea-seoul-st-marys-hospital/)
- [The Catholic University of Korea St. Vincent's Hospital](https://kuraoncology.com/ct-locations/the-catholic-university-of-korea-st-vincents-hospital/)
- [Haukeland Universitetssjukehus](https://kuraoncology.com/ct-locations/haukeland-universitetssjukehus/)
- [Radiumhospitalet](https://kuraoncology.com/ct-locations/radiumhospitalet/)
- [Universitair Medisch Centrum Groningen](https://kuraoncology.com/ct-locations/universitair-medisch-centrum-groningen/)
- [Maastricht University Medical Centre](https://kuraoncology.com/ct-locations/maastricht-university-medical-centre/)
- [Universitair Medisch Centrum Utrecht](https://kuraoncology.com/ct-locations/universitair-medisch-centrum-utrecht/)
- [University Malaya Medical Centre](https://kuraoncology.com/ct-locations/university-malaya-medical-centre/)
- [Institut Kanser Negara](https://kuraoncology.com/ct-locations/institut-kanser-negara/)
- [Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola-Malpighi](https://kuraoncology.com/ct-locations/azienda-ospedaliero-universitaria-di-bologna-policlinico-santorsola-malpighi/)
- [Azienda Ospedaliera S. Croce e Carle Cuneo](https://kuraoncology.com/ct-locations/azienda-ospedaliera-s-croce-e-carle-cuneo/)
- [Ospedale Mater Salutis di Legnago](https://kuraoncology.com/ct-locations/ospedale-mater-salutis-di-legnago/)
- [Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori](https://kuraoncology.com/ct-locations/istituto-scientifico-romagnolo-per-lo-studio-e-la-cura-dei-tumori/)
- [Fondazione IRCCS - Istituto Nazionale dei Tumori - Milano](https://kuraoncology.com/ct-locations/fondazione-irccs-istituto-nazionale-dei-tumori-milano/)
- [Istituto Nazionale Tumori IRCCS Fondazione Pascale](https://kuraoncology.com/ct-locations/istituto-nazionale-tumori-irccs-fondazione-pascale/)
- [Azienda Ospedaliera Universitaria Senese-L'ospedale Santa Maria alle Scotte](https://kuraoncology.com/ct-locations/azienda-ospedaliera-universitaria-senese-lospedale-santa-maria-alle-scotte/)
- [University General Hospital of Athens Attikon](https://kuraoncology.com/ct-locations/university-general-hospital-of-athens-attikon/)
- [University General Hospital of Larissa](https://kuraoncology.com/ct-locations/university-general-hospital-of-larissa/)
- [Bioclinic - Thessaloniki](https://kuraoncology.com/ct-locations/bioclinic-thessaloniki/)
- [Charité Universitätsmedizin Berlin](https://kuraoncology.com/ct-locations/charite-universitatsmedizin-berlin/)
- [Universitätsklinikum Leipzig](https://kuraoncology.com/ct-locations/universitatsklinikum-leipzig/)
- [Universitätsmedizin Mannheim](https://kuraoncology.com/ct-locations/universitatsmedizin-mannheim/)
- [Universitätsklinikum Würzburg](https://kuraoncology.com/ct-locations/universitatsklinikum-wurzburg/)
- [Rigshospitalet](https://kuraoncology.com/ct-locations/rigshospitalet/)
- [Herlev Hospital](https://kuraoncology.com/ct-locations/herlev-hospital/)
- [Ziekenhuis Netwerk Antwerpen Middelheim](https://kuraoncology.com/ct-locations/ziekenhuis-netwerk-antwerpen-middelheim/)
- [Cliniques Universitaires Saint-Luc](https://kuraoncology.com/ct-locations/cliniques-universitaires-saint-luc/)
- [Universitair Ziekenhuis Antwerpen](https://kuraoncology.com/ct-locations/universitair-ziekenhuis-antwerpen/)
- [Universitair Ziekenhuis Leuven](https://kuraoncology.com/ct-locations/universitair-ziekenhuis-leuven/)
- [Centre Hospitalier Universitaire Universite Catholique de Louvain Site Godinne](https://kuraoncology.com/ct-locations/centre-hospitalier-universitaire-universite-catholique-de-louvain-site-godinne/)
- [Allgemeines Krankenhaus der Stadt Wien](https://kuraoncology.com/ct-locations/allgemeines-krankenhaus-der-stadt-wien/)
- [Hanusch Krankenhaus Wiener Gebietskrankenkasse](https://kuraoncology.com/ct-locations/hanusch-krankenhaus-wiener-gebietskrankenkasse/)
- [Peter MacCallum Cancer Centre](https://kuraoncology.com/ct-locations/peter-maccallum-cancer-centre/)
- [Royal North Shore Hospital](https://kuraoncology.com/ct-locations/royal-north-shore-hospital/)
- [Test Location](https://kuraoncology.com/ct-locations/test-location/)

## Media Images

- [Francis Burrows, Ph.D.](https://kuraoncology.com/media-images/francis-burrows-ph-d/)
- [Mollie Leoni, M.D.](https://kuraoncology.com/media-images/mollie-leoni-m-d/)
- [Troy Wilson, Ph.D., J.D.](https://kuraoncology.com/media-images/troy-wilson-ph-d-j-d/)
- [Kura Oncology Office Interior <br> Boston (3)](https://kuraoncology.com/media-images/kura-oncology-office-interior-boston-3/)
- [Kura Oncology Office Interior <br> Boston (2)](https://kuraoncology.com/media-images/kura-oncology-office-interior-boston-2/)
- [Kura Oncology Office Interior <br> Boston (1)](https://kuraoncology.com/media-images/kura-oncology-office-interior-2/)
- [Kura Oncology Office Interior <br> San Diego (3)](https://kuraoncology.com/media-images/kura-oncology-office-interior-san-diego-3/)
- [Kura Oncology Office Interior <br> San Diego (2)](https://kuraoncology.com/media-images/kura-oncology-office-interior-san-diego-2/)
- [Kura Oncology Office Interior <br> San Diego (1)](https://kuraoncology.com/media-images/kura-oncology-office-interior/)
- [Brian Powl](https://kuraoncology.com/media-images/brian-powl/)
- [Roger Bakale](https://kuraoncology.com/media-images/roger-bakale/)
- [Tom Doyle](https://kuraoncology.com/media-images/tom-doyle/)
- [Kathy Ford](https://kuraoncology.com/media-images/kathleen-ford/)
- [Teresa Bair, J.D.](https://kuraoncology.com/media-images/teresa-bair-j-d/)

## Perspectives

- [Kura Oncology Named 2025 Fierce 50 Honoree](https://www.fiercepharma.com/fierce-50/kura-oncology#new_tab)
- [Kura CMO Mollie Leoni Featured as <em>In Vivo</em> 2025 Rising Leader](https://insights.citeline.com/in-vivo/leadership/rising-leaders/rising-leaders-2025-kura-oncologys-mollie-leoni-on-setting-precedent-not-following-it-NR2FQFOVC5DPNECPKPEQBDGU3Y/)
- [2025 Scrip Awards Deal of the Year Finalist](https://www.citeline.com/en/awards/scripawards#new_tab)
- [SDUT San Diego Top Workplaces 2024](https://topworkplaces.com/award/sandiego/2024/50-149/?page=1#new_tab)
- [Kura CEO Troy Wilson Named an EY Entrepreneur Of The Year<sup>®</sup> 2025 Pacific Southwest Award Winner](https://kuraoncology.com/perspectives/kura-ceo-troy-wilson-named-an-ey-entrepreneur-of-the-year-2025-pacific-southwest-award-winner/)
- [Achievement in Operational Excellence to Deliver Business Transformation](https://kuraoncology.com/perspectives/achievement-in-operational-excellence-to-deliver-business-transformation/)
- [Thank You, From Kura Oncology](https://kuraoncology.com/perspectives/thank-you-from-kura-oncology/)
- [Progress By Collaboration: The Development of Kura’s Menin Inhibitor for AML Research](https://kuraoncology.com/perspectives/progress-by-collaboration-the-development-of-kuras-menin-inhibitor-for-aml-research/)
- [Scrip Asks... What Does 2025 Hold For Biopharma? Part 5: Clinical Trials Trends](https://kuraoncology.com/perspectives/scrip-asks-what-does-2025-hold-for-biopharma-part-5-clinical-trials-trends/)
- [PharmaVoice’s Crystal Ball: Industry shifts in R&D, policy and clinical trials](https://kuraoncology.com/perspectives/pharmavoices-crystal-ball-industry-shifts-in-rd-policy-and-clinical-trials/)
- [Asking the Right Questions in R&D](https://kuraoncology.com/perspectives/asking-the-right-questions-in-rd/)
- [AML World Awareness Day and Kura’s Commitment](https://kuraoncology.com/perspectives/aml-world-awareness-day-and-kuras-commitment/)
- [Kura Core Values](https://kuraoncology.com/perspectives/kura-core-values/)
- [Navigating Dose Optimization Requirements as a Small Biotech](https://kuraoncology.com/perspectives/navigating-dose-optimization-requirements-as-a-small-biotech/)
- [From Lab to Clinic: The Origin and Journey of Menin Inhibitors for AML Research](https://kuraoncology.com/perspectives/from-lab-to-clinic-the-origin-and-journey-of-menin-inhibitors-for-aml-research/)
- [Breakthrough Therapy Designation Granted for Ziftomenib in R/R NPM1-Mutant AML](https://kuraoncology.com/perspectives/breakthrough-therapy-designation-granted-for-ziftomenib-in-r-r-npm1-mutant-aml/)
- [Menin inhibitors seek to debut as newest targeted therapy for leukaemia](https://kuraoncology.com/perspectives/menin-inhibitors-seek-to-debut-as-newest-targeted-therapy-for-leukaemia/)
- [Kura Oncology Reports Preliminary Data From Menin Inhibitor, Chemo Combination Trial in AML](https://kuraoncology.com/perspectives/kura-oncology-reports-preliminary-data-from-menin-inhibitor-chemo-combination-trial-in-aml/)
- [PharmaVoice 100 Top Industry Leaders: Kathy Ford](https://www.pharmavoice.com/news/pv100-pharma-leaders-executives/726233/#new_tab)
- [2024 Scrip Awards Community Partnership of the Year: Kura Oncology and Life Science Cares<br><br>2024 Scrip Awards Executive of the Year: Troy Wilson, Ph.D., J.D.](https://www.citeline.com/en/awards/scripawards#Categories-anchor#new_tab)
- [Kura Makes Fast Company’s 100 Best Workplaces for Innovators List](https://kuraoncology.com/perspectives/kura-makes-fast-companys-100-best-workplaces-for-innovators-list/)
- [Kura CEO Troy Wilson on the Inflation Reduction Act](https://kuraoncology.com/perspectives/kura-ceo-troy-wilson-on-the-inflation-reduction-act/)
- [Kura Oncology Supports Life Science Cares’ "Food is Medicine" Initiative](https://kuraoncology.com/perspectives/kura-oncology-supports-life-science-cares-food-is-medicine-initiative/)
- [Accelerating Bio Innovation 2024](https://kuraoncology.com/perspectives/accelerating-bio-innovation-2024/)
- [Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni, Kura Oncology](https://kuraoncology.com/perspectives/menin-inhibition-shows-potential-for-precision-therapy-in-aml-with-dr-mollie-leoni-kura-oncology/)
- [AML World Awareness Day 2024](https://kuraoncology.com/perspectives/aml-world-awareness-day-2024/)
- [2024 Citeline Awards Excellence in Patient Recruitment & Engagement](https://kuraoncology.com/perspectives/2024-citeline-awards-excellence-in-patient-recruitment-engagement/)
- [Moving Forward, Giving Back: The ROI of Social Impact](https://kuraoncology.com/perspectives/moving-forward-giving-back-the-roi-of-social-impact/)
- [Kura’s Leukemia Treatment Performs Best When Tacked Onto Existing Combo, New Data Show](https://kuraoncology.com/perspectives/kuras-leukemia-treatment-performs-best-when-tacked-onto-existing-combo-new-data-show/)
- [Ziftomenib Combos Show Early Safety, Activity in NPM1-Mutant and KMT2A-Rearranged AML](https://kuraoncology.com/perspectives/ziftomenib-combos-show-early-safety-activity-in-npm1-mutant-and-kmt2a-rearranged-aml/)
- [Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends](https://scrip.citeline.com/SC149726/Scrip-AsksWhat-Does-2024-Hold-For-Biopharma-Part-5-Clinical-Trial-Trends#new_tab)
- [PharmaVoice’s Crystal Ball: Perspectives on the financial future](https://kuraoncology.com/perspectives/pharmavoices-crystal-ball-perspectives-on-the-financial-future/)
- [Kathy Ford, R.N., B.S.N., Kura COO, on Ordinarily Extraordinary - Conversations with Women in STEM podcast](https://kuraoncology.com/perspectives/kathy-ford-r-n-b-s-n-kura-coo-on-ordinarily-extraordinary-conversations-with-women-in-stem-podcast/)
- [The Promise of Precision Oncology, Troy Wilson, President & CEO, Kura Oncology](https://kuraoncology.com/perspectives/the-promise-of-precision-oncology-troy-wilson-president-ceo-kura-oncology/)
- [Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place](https://kuraoncology.com/perspectives/manufacturing-and-supply-chain-making-space-between-a-rock-and-a-hard-place/)
- [SDUT San Diego Top Workplaces 2023](https://kuraoncology.com/perspectives/sdut-san-diego-top-workplaces-2023/)
- [Kura Oncology's CEO gives an update on Q3 earnings](https://kuraoncology.com/perspectives/kura-oncologys-ceo-gives-an-update-on-q3-earnings/)
- [2023 Scrip Awards Best Oncology R&D Advance](https://kuraoncology.com/perspectives/2023-scrip-awards-best-oncology-rd-advance/)
- [PharmaVoice 100 Top Industry Leaders: Teresa Bair, J.D.](https://kuraoncology.com/perspectives/pharmavoice-100-top-industry-leaders-teresa-bair-j-d/)
- [CEO Troy Wilson On Giving Back: Empowering Young Minds to Explore Life Sciences](https://kuraoncology.com/perspectives/ceo-troy-wilson-on-giving-back-empowering-young-minds-to-explore-life-sciences/)
- [What pharma can teach biotech about the life cycle management of a drug](https://kuraoncology.com/perspectives/what-pharma-can-teach-biotech-about-the-life-cycle-management-of-a-drug/)
- [Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC with HRAS Mutations](https://kuraoncology.com/perspectives/tipifarnib-demonstrates-encouraging-efficacy-in-patients-with-recurrent-and-or-metastatic-hnscc-with-hras-mutations/)
- [PharmaVoice 100: Entrepreneurs](https://kuraoncology.com/perspectives/pharmavoice-100-entrepreneurs/)
- [PharmaVoice 100: Innovator’s Journey](https://kuraoncology.com/perspectives/pharmavoice-100-innovators-journey/)
- [SDUT San Diego Top Workplaces 2021](https://kuraoncology.com/perspectives/sdut-san-diego-top-workplaces-2021/)
- [SDUT San Diego Top Workplaces 2022](https://kuraoncology.com/perspectives/sdut-san-diego-top-workplaces-2022/)
- [Is This the Dawn of Precision Oncology in Head and Neck Cancer?](https://kuraoncology.com/perspectives/is-this-the-dawn-of-precision-oncology-in-head-and-neck-cancer/)
- [BIO: Kura Oncology CEO Wilson on the power of biotech in the quest beyond KRAS](https://kuraoncology.com/perspectives/bio-kura-oncology-ceo-wilson-on-the-power-of-biotech-in-the-quest-beyond-kras/)
- [Liquid Biopsies Guide the Development of Cancer Drugs](https://kuraoncology.com/perspectives/liquid-biopsies-guide-the-development-of-cancer-drugs/)
- [The Medicine Maker Power List 2023: Francis Burrows](https://kuraoncology.com/perspectives/the-medicine-maker-power-list-2023-francis-burrows/)
- [San Diego Business Journal Leaders of Influence in Life Science 2023 Honorees](https://kuraoncology.com/perspectives/san-diego-business-journal-leaders-of-influence-in-life-science-2023-honorees/)
- [CEO Troy Wilson on Navigating a Clinical Stage Biopharmaceutical Company Through the Pandemic](https://kuraoncology.com/perspectives/ceo-troy-wilson-on-navigating-a-clinical-stage-biopharmaceutical-company-through-the-pandemic/)
- [FDA’s Renewed Focus on Oncology Dosing Spooks Investors, but Companies Say They’re Ready](https://kuraoncology.com/perspectives/fdas-renewed-focus-on-oncology-dosing-spooks-investors-but-companies-say-theyre-ready/)
- [CEO Troy Wilson on Sailing Through the Storm: Lessons from the Pandemic](https://kuraoncology.com/perspectives/ceo-troy-wilson-on-sailing-through-the-storm-lessons-from-the-pandemic/)
- [COO Kathy Ford on What Makes Kura a Top Workplace](https://kuraoncology.com/perspectives/coo-kathy-ford-on-what-makes-kura-a-top-workplace/)
- [The History and Culture of Kura](https://kuraoncology.com/perspectives/the-history-and-culture-of-kura/)
- [San Diego Business Journal CEO of the Year Awards 2023 Finalists](https://kuraoncology.com/perspectives/san-diego-business-journal-ceo-of-the-year-awards-2023-finalists/)
- [World Medical Innovation Forum Panel  on The Innovation Gap: The Promise of Precision Oncology for Liquid Tumors](https://kuraoncology.com/perspectives/world-medical-innovation-forum-panel-on-the-innovation-gap-the-promise-of-precision-oncology-for-liquid-tumors/)
- [Kura Oncology 2022 Annual Report](https://kuraoncology.com/perspectives/kura-oncology-2022-annual-report/)

## Categories

- [AIM](https://kuraoncology.com/category/aim/)
- [Global](https://kuraoncology.com/category/aim/global-aim/)
- [Australia](https://kuraoncology.com/category/aim/global-aim/australia-aim/)
- [Austria](https://kuraoncology.com/category/aim/global-aim/austria-aim/)
- [Belgium](https://kuraoncology.com/category/aim/global-aim/belgium-aim/)
- [Denmark](https://kuraoncology.com/category/aim/global-aim/denmark-aim/)
- [Germany](https://kuraoncology.com/category/aim/global-aim/germany-aim/)
- [Greece](https://kuraoncology.com/category/aim/global-aim/greece-aim/)
- [Italy](https://kuraoncology.com/category/aim/global-aim/italy-aim/)
- [Malaysia](https://kuraoncology.com/category/aim/global-aim/malaysia-aim/)
- [Netherlands](https://kuraoncology.com/category/aim/global-aim/netherlands-aim/)
- [Norway](https://kuraoncology.com/category/aim/global-aim/norway-aim/)
- [Republic of Korea](https://kuraoncology.com/category/aim/global-aim/republic-korea-aim/)
- [Spain](https://kuraoncology.com/category/aim/global-aim/spain-aim/)
- [Taiwan](https://kuraoncology.com/category/aim/global-aim/taiwan-aim/)
- [Thailand](https://kuraoncology.com/category/aim/global-aim/thailand-aim/)
- [United Kingdom](https://kuraoncology.com/category/aim/global-aim/united-kingdom-aim/)
- [United States](https://kuraoncology.com/category/aim/state-aim/)
- [California](https://kuraoncology.com/category/aim/state-aim/california-aim/)
- [Florida](https://kuraoncology.com/category/aim/state-aim/florida-aim/)
- [Georgia](https://kuraoncology.com/category/aim/state-aim/georgia-aim/)
- [Kansas](https://kuraoncology.com/category/aim/state-aim/kansas-aim/)
- [Kentucky](https://kuraoncology.com/category/aim/state-aim/kentucky-aim/)
- [Maryland](https://kuraoncology.com/category/aim/state-aim/maryland-aim/)
- [Massachusetts](https://kuraoncology.com/category/aim/state-aim/massachusetts-aim/)
- [Michigan](https://kuraoncology.com/category/aim/state-aim/michigan-aim/)
- [Minnesota](https://kuraoncology.com/category/aim/state-aim/minnesota-aim/)
- [Missouri](https://kuraoncology.com/category/aim/state-aim/missouri-aim/)
- [New York](https://kuraoncology.com/category/aim/state-aim/new-york-aim/)
- [North Carolina](https://kuraoncology.com/category/aim/state-aim/north-carolina-aim/)
- [Oklahoma](https://kuraoncology.com/category/aim/state-aim/oklahoma-aim/)
- [Pennsylvania](https://kuraoncology.com/category/aim/state-aim/pennsylvania-aim/)
- [Tennessee](https://kuraoncology.com/category/aim/state-aim/tennessee-aim/)
- [Washington](https://kuraoncology.com/category/aim/state-aim/washington-aim/)
- [Wisconsin](https://kuraoncology.com/category/aim/state-aim/wisconsin-aim/)
- [Komet](https://kuraoncology.com/category/komet/)
- [Global](https://kuraoncology.com/category/komet/global-komet/)
- [France](https://kuraoncology.com/category/komet/global-komet/france-komet/)
- [Italy](https://kuraoncology.com/category/komet/global-komet/italy-komet/)
- [Spain](https://kuraoncology.com/category/komet/global-komet/spain-komet/)
- [United States](https://kuraoncology.com/category/komet/united-states-komet/)
- [Arizona](https://kuraoncology.com/category/komet/united-states-komet/arizona-komet/)
- [California](https://kuraoncology.com/category/komet/united-states-komet/california-komet/)
- [Florida](https://kuraoncology.com/category/komet/united-states-komet/florida-komet/)
- [Illinois](https://kuraoncology.com/category/komet/united-states-komet/illinois-komet/)
- [Indiana](https://kuraoncology.com/category/komet/united-states-komet/indiana-komet/)
- [Maryland](https://kuraoncology.com/category/komet/united-states-komet/maryland-komet/)
- [Massachusetts](https://kuraoncology.com/category/komet/united-states-komet/massachusetts-komet/)
- [Michigan](https://kuraoncology.com/category/komet/united-states-komet/michigan-komet/)
- [Minnesota](https://kuraoncology.com/category/komet/united-states-komet/minnesota-komet/)
- [New Jersey](https://kuraoncology.com/category/komet/united-states-komet/new-jersey-komet/)
- [New York](https://kuraoncology.com/category/komet/united-states-komet/new-york-komet/)
- [North Carolina](https://kuraoncology.com/category/komet/united-states-komet/north-carolina-komet/)
- [Pennsylvania](https://kuraoncology.com/category/komet/united-states-komet/pennsylvania-komet/)
- [Tennessee](https://kuraoncology.com/category/komet/united-states-komet/tennessee-komet/)
- [Texas](https://kuraoncology.com/category/komet/united-states-komet/texas-komet/)
- [Washington](https://kuraoncology.com/category/komet/united-states-komet/washington-komet/)
- [Kurrent](https://kuraoncology.com/category/kurrent/)
- [United States](https://kuraoncology.com/category/kurrent/state-kurrent/)
- [California](https://kuraoncology.com/category/kurrent/state-kurrent/california-kurrent/)
- [Florida](https://kuraoncology.com/category/kurrent/state-kurrent/florida-kurrent/)
- [Massachusetts](https://kuraoncology.com/category/kurrent/state-kurrent/massachusetts-kurrent/)
- [Missouri](https://kuraoncology.com/category/kurrent/state-kurrent/missouri-kurrent/)
- [New York](https://kuraoncology.com/category/kurrent/state-kurrent/new-york-kurrent/)
- [Pennsylvania](https://kuraoncology.com/category/kurrent/state-kurrent/pennsylvania-kurrent/)
- [Leadership In The News](https://kuraoncology.com/category/leadership-in-the-news/)
- [Currents](https://kuraoncology.com/category/currents/)
- [Maryland](https://kuraoncology.com/category/kurrent/state-kurrent/maryland-kurrent/)
- [Texas](https://kuraoncology.com/category/kurrent/state-kurrent/texas-kurrent/)
- [Wisconsin](https://kuraoncology.com/category/kurrent/state-kurrent/wisconsin-kurrent/)
- [videos](https://kuraoncology.com/category/videos/)
- [Germany](https://kuraoncology.com/category/komet/global-komet/germany-komet/)
- [Oklahoma](https://kuraoncology.com/category/komet/united-states-komet/oklahoma-komet/)
- [Perspectives](https://kuraoncology.com/category/perspectives/)
- [Awards](https://kuraoncology.com/category/perspectives/type/awards/)
- [Kura Kommentary](https://kuraoncology.com/category/perspectives/type/kura-kommentary/)
- [Media Coverage](https://kuraoncology.com/category/perspectives/type/media-coverage/)
- [Life at Kura](https://kuraoncology.com/category/perspectives/type/life-at-kura/)
- [Year](https://kuraoncology.com/category/perspectives/year/)
- [2020](https://kuraoncology.com/category/perspectives/year/2020/)
- [2021](https://kuraoncology.com/category/perspectives/year/2021/)
- [2022](https://kuraoncology.com/category/perspectives/year/2022/)
- [2023](https://kuraoncology.com/category/perspectives/year/2023/)
- [Type](https://kuraoncology.com/category/perspectives/type/)
- [Imagery](https://kuraoncology.com/category/imagery/)
- [Office](https://kuraoncology.com/category/imagery/office/)
- [Leadership](https://kuraoncology.com/category/imagery/leadership/)
- [Fathi](https://kuraoncology.com/category/videos/fathi/)
- [Zeidan](https://kuraoncology.com/category/videos/zeidan/)
- [Erba](https://kuraoncology.com/category/videos/erba/)
- [2024](https://kuraoncology.com/category/perspectives/year/2024/)
- [link_off](https://kuraoncology.com/category/link_off/)
- [2025](https://kuraoncology.com/category/perspectives/year/2025/)

## Portfolio Categories

- [Leadership](https://kuraoncology.com/leadership/leadership/)
- [Board of Directors](https://kuraoncology.com/leadership/board-of-directors/)